// App-Quantinova.ai

TCT-430 : Nine-Month Angiographic and 1-Year Clinical Outcomes of the RECOVERY Study: A Randomized Trial Evaluating the Safety and Efficacy of the Combo Bio-Engineered Sirolimus-Eluting Stent Versus the Nano Polymer-Free Sirolimus-Eluting Stent in Patients with Coronary Artery Disease

Researchers

Presenter

  • Ling Tao

Principal Investigators

  • Zhanquan Li

  • Zhiyong Yin

  • Wenhua Lin

  • Yin Liu

  • Hui Li

  • Bo Yu

  • Wei Li

  • Helen Lau

  • Bo Xu

Medical Centers

  • Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, Beijing, China, Beijing, China

  • The First Affiliated Hospital of the Forth Military Medical University, Xi'an, China

  • The People's Hospital of Liaoning Province, Shenyang, China

  • Medical Research & Biometrics Center of National Center for Cardiovascular Disease, Beijing, Beijing, China

  • Teda International Cardiovascular Hospital, Tianjin, Tianjin, China

  • Daqing Oilfields General Hospital, Daqing, Heilongjiang, China

  • Tianjin Chest Hospital, Tianjin, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Coronary artery lesions

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • Randomized

  • Non Inferiority

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved